1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia

Details for Australian Patent Application No. 2004205642 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Jones, Robert M.; Calderon, Imelda; Dave, Vibha; Choi, Jin Sun Karoline; Semple, Graeme; Fioravanti, Beatriz; Pereira, Guilherme; Azimoara, Mihai D.; Uy, Jane; Xiong, Yifeng; Duvvuri, Kameshwari

Agent FB Rice

Pub. Number AU-B-2004205642

PCT Pub. Number WO2004/065380

Priority 60/453,390 06.03.03 US; 60/449,829 24.02.03 US; 60/470,875 14.05.03 US; 60/440,394 14.01.03 US

Filing date 14 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 27 January 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/79 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/50 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 295/096 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 411/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 419/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms

Event Publications

23 June 2005 PCT application entered the National Phase

  PCT publication WO2004/065380 Priority application(s): WO2004/065380

6 December 2007 Amendment Made

  The nature of the amendment is: Add co-inventor Azimoara, Mihai D

27 January 2011 Application Accepted

  Published as AU-B-2004205642

26 May 2011 Standard Patent Sealed

12 January 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 Jul 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004205643-Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA

2004205640-Selectively activatable food storage wrap sheet